Abstract
A concise and one-pot cascade method has been developed to achieve the synthesis of difluoroboron-derivatized curcumins (BF2C). Treatment of 2,4-pentanedione with BF3·OEt2, followed by condensation with aldehydes in the presence of tributyl borate and butylamine at 65 °C in toluene furnished the corresponding symmetric (s-BF2C) and unsymmetric difluoroboron-derivatized curcumins (us-BF2C) in good (60 - 99%) and moderate yields (23 - 42%) within 6 - 12 h, respectively.

Keywords: BF3-Et2O promoted reaction, concise synthesis, difluoroboron complex, Curcumin analog
Curcumin, a yellow spice and pigment isolated from the rhizome of Curcuma longa, has been traditionally and widely used as a food coloring additive.1 Recently, curcumin has attracted extensive attention in biomedical research as multiple biological activities of curcumin have been revealed including antioxidant, anti-inflammatory, biometal chelating, anti-proliferative, and anti-Aβ activities, among others.2-5 Consequently, curcumin has been tested in various disease models, such as arthritis, cancer, and Alzheimer’s disease (AD) as both a preventive and treatment agent.6-10 Since curcumin itself possesses a number of properties that limit its potential as an effective medicinal agent, e.g., poor solubility and bioavailability, extensive efforts have been made to develop more effective analogues with improved pharmacokinetic and pharmacological properties. Among the analogues developed, a difluoroboron complex of curcumin was initially developed with increased stability and inhibitory potency against HIV protease.11 Furthermore, the difluoroboron-derivatized curcumin analogues such as CRANAD-2 and BF2C have been demonstrated as novel near-infrared imaging (NIR) probes to detect Aβ plaques in AD and as chemical sensors for cyanide detection, In addition, detailed photophysical and photochemical research disclosed that the optical properties can be optimized for different purposes by phenyl ring modifications, thus indicating both therapeutic and diagnostic applications of such difluoroboron-derivatized curcumin analogues.12,13
Despite the broad spectrum of biological activities and potential applications for boron complexes of curcumin analogues, the synthetic methodology to produce such analogues has remained quite limited. The BF2C analogues are typically prepared by a two-step process employing A) 2,4-pentanedione and aldehydes or B) curcumin in the presence of BF3·OEt2 and Et3N (Scheme 1). But these methods generally require long reaction times and give typical low yields over the two steps. In addition, curcumin analogues with substituents on phenolic oxygens are typically synthesized by employing the Pabon reaction in another two-step process with low yields.14 Therefore, a more concise and more efficient method is needed to prepare such analogues. As part of our ongoing studies developing novel curcumin analogues as multifunctional ligands for AD treatment,15,16,17 we herein report a new and concise method that allows one-pot selective synthesis of symmetrical (s-BF2C) or unsymmetrical difluoroboron-curcumin analogues (us-BF2C) via a BF3·OEt2 promoted system. Furthermore, these BF2C analogues can be used as intermediates to deliver a wide range of symmetric and unsymmetric substituted curcumin analogues for biological screening.
Scheme 1.

Traditional Methods for preparation of BF2C.
First, we selected 2,4-pentanedione and vanillin as the model system to optimize the reaction conditions. Preliminary studies revealed that reaction of vanillin with 2,4-pentanedione in DMF in the presence of excess of BF3·OEt2 (1.5 equiv) and catalytic amount of n-BuNH2 afforded only a trace amount of 2a (Table 1, entry 1). Efforts were then made to optimize the reaction conditions. As shown in Table 1, the addition of tributyl borate as dehydrating agent greatly improves the yield in this type of reaction. Of the solvents screened, toluene afforded 2a in 94% yield at 65 °C (entry 8). No significant improvement in reaction yield was observed when the reaction was carried out at 100 °C (entry 9). Notably, the difluoroboron-curcumin analogue 2a was precipitated from toluene, and the purity was determined to be > 92% by HPLC, thus making the isolation and purification process in this method quite practical and accessible.
Table 1.
Optimization of the BF3·OEt2-Promoted One-Pot Synthesis of Difluoroboron-Derivatized Curcumin (BF2C)a

| entry | solvent | additive | temp | time (h)b |
yield of 2a (%)c |
|---|---|---|---|---|---|
| 1 | DMF | none | 65 | 12 | <5 d |
| 2 | DMF | (n-BuO)3B | 65 | 12 | 30 d |
| 3 | DMF | (n-BuO)3B | 100 | 24 | 32d |
| 4 | EtOAc | none | 65 | 12 | 15 d |
| 5 | EtOAc | (n-BuO)3B | 65 | 12 | 80 |
| 6 | Hexane | (n-BuO)3B | 65 | 12 | 74 |
| 7 | CHCl3 | (n-BuO)3B | 65 | 12 | 81 |
| 8 | Toluene | (n-BuO)3B | 65 | 12 | 94 |
| 9 | Toluene | (n-BuO)3B | 100 | 12 | 95 |
| 10 | MeCN | (n-BuO)3B | 65 | 12 | 70 |
| 11 | cyclohexane | (n-BuO)3B | 65 | 12 | 68 |
| 12 | THF | (n-BuO)3B | 65 | 12 | 54 |
| 13 | DMAC | (n-BuO)3B | 65 | 24 | 35 d |
| 14 | 1,4-dioxane | (n-BuO)3B | 65 | 12 | 70 |
| 15 | DMSO | (n-BuO)3B | 65 | 24 | 40 d |
Reaction conditions: 2,4-pentanedione (0.2 mmol) and BF3·OEt2 (0.3 mmol) were reacted in 2 mL of solvent under a nitrogen atmosphere in a Schlenk tube for 2 h. Then vanillin (1a, 0.4 mmol), tributyl borate (0.4 mmol except entries 1 and 4) and butylamine (0.04 mmol) were added subsequently, and the reaction was continued for indicated intervals.
The reaction was monitored by TLC.
Yield of precipitated product.
Isolated yields from flash chromatography.
With the optimized reaction conditions established (Table 1, entry 8), the scope of the BF3·OEt2-mediated reaction of 2,4-pentanedione and aldehydes was then studied. As shown in Table 2, all the adehydes tested yielded s-BF2C in good to excellent yields. In general, substitutions on the phenyl ring of aryl aldehydes are well tolerated under the experimental conditions, and both electron-donating and electron-withdrawing subtituents improved the yield slightly compared to unsubstituted compound (entry 2) while with electron-donating substituents being better than electron-withdrawing substituents. Notably, the current method provided significantly improved reaction yield when compared to the reported procedure as demonstrated by the synthesis of compound 2f (Table 2, entry 6).12 Furthermore, when benzaldehyde (entry 2) was replaced with a naphthalene-2-carbaldehyde (entry 11) or pyridine-3-carbaldehyde (entry 12), the yield was significantly improved, while replacement with cinnamaldehyde (entry 13) afforded a significantly reduced reaction yield. These observations may indicate that the benzylidene moiety is essential for the complex formation. This notion is further supported by the reduced yield of cyclopropanecarboxaldehyde (entry 14, 60% yield). Since cyclopropanecarboxaldehyde also gave a reasonable yield of 60%, this may suggest that non-aromatic aldehydes could be good substrates for this reaction system. To further confirm this, we tested propionaldehyde and 3-phenyl-propionaldehyde in this reaction system. Surprisingly, no reaction was observed for both non-aromatic aldehyde substrates. The reaction of cyclopropanecarboxaldehyde may be due to the increased sp2 nature of the cyclopropane in this specific aldehyde, thus indicating that aromatic aldehyde is best suited to this reaction system.
Table 2.
Reaction of Aldehydes 1 and 2,4-Pentanedione for the Synthesis of Symmetric Difluoroboron-derivatized Curcumins 2 (s-BF2C) a

| entry | Ar1 | time (h)b |
purity (%)c |
yield of 2 (%)d |
|---|---|---|---|---|
| 1 | 3-MeO-4-OH-C6H3- | 12 | 96 | 94(2a) |
| 2 | C6H5- | 12 | 94 | 80(2b) |
| 3 | 4-HO-C6H4- | 6 | 95 | 99(2c) |
| 4 | 4-MeO-C6H4- | 8 | 93 | 95(2d) |
| 5 | 4-Me-C6H3- | 12 | 97 | 87(2e) |
| 6 | 4-Me2N-C6H4- | 8 | 96 | 85(2f) |
| 7 | 4-F-C6H4- | 12 | 97 | 79(2g) |
| 8 | 4-Cl-C6H4- | 12 | 97 | 75(2h) |
| 9 | 4-Br-C6H4- | 12 | 95 | 84(2i) |
| 10 | 3-NO2-C6H4- | 12 | 99 | 81(2j) |
| 11 |
|
12 | 98 | 94(2k) |
| 12 |
|
12 | 99 | 96(2l) |
| 13 |
|
12 | 99 | 60(2m) |
| 14 |
|
24 | 97e | 60(2n) |
| 15 | 3,4,5-(MeO)3C6H2- | 12 | 96 | 92(2o) |
Reaction conditions: 2,4-pentanedione (0.2 mmol) and BF3·OEt2 (0.3 mmol) were reacted in 2 mL of solvent under a nitrogen atmosphere in a Schlenk tube for 2 h. Then aldehyde (1, 0.4 mmol), tributyl borate (0.4 mmol) and butylamine (0.04 mmol) were added subsequently, and the reaction was continued for several hours.
The reaction was monitored by TLC.
Determined by HPLC.
Isolated yields.
Purified by silica gel column chromatography.
The transformation of aldehyde and 2,4-pentanedione to BF2C under the BF3·OEt2-promoted reaction likely proceeds via a similar mechanism to that of reported procedure12 as is outlined in Scheme 2. The significant improvement of reaction yield in our method may be due to the fact that the product can be precipitated from the reaction mixture, thus driving the continuing consumption of the starting aldehyde and the difluoroboron-2,4-pentanedione intermediate. Further studies are needed to understand the mechanism of this method better. Multicomponent reactions are becoming increasingly important because they deliver complex and diverse chemical entities from relatively simple starting materials in a one-pot reaction.18 With the optimal reaction conditions established for the synthesis of s-BF2C, we investigated the feasibility of developing a multicomponent version of this method to achieve synthesis of us-BF2C. If successful, such a methodology will provide an efficient way to deliver unsymmteric curcumin analogues and this will consequently facilitate the drug development process of such compounds. We initially employed four aldehydes to react with vanillin to test the feasibility and the results are summarized in Table 3. Under the same conditions employed in Table 2, one pot reaction with two different aldehydes afforded us-BF2C (Table 3) in acceptable yields, albeit significantly lower than the mono-aldehyde versions. The reactions afforded the us-BF2C either as a major product (entry 1, Table 3) or with comparable yield to the s-BF2C (entries 2, 3, and 4 of Table 3, two s-BF2C products), thus suggesting that further optimization is necessary to improve the yield of us-BF2C. Notably, the 4-HO-benzaldehyde provided the best yield among the aldehydes tested, consistent with results from Table 2. However, the yield from pyridine-3-carbaldehyde was lower when compared to the results from Table 2.
Scheme 2.

Possible pathways towards symmetric s-BF2C.
Table 3.
Reaction of Vanillin (1a), Aldehydes 3 and 2,4-Pentanedione for the Synthesis of Asymmetric Difluoroboron-Derivatized Curcumins 4a

| entry | Ar2 | time (h)c |
yield of 4 (%)c |
|---|---|---|---|
| 1 | 4-HO-C6H4- | 6 | 42(4a) |
| 2 | 4-Br-C6H4- | 12 | 23(4b) |
| 3 | 4-NO2-C6H4- | 24 | 25(4c) |
| 4 |
|
12 | 28(4d) |
Reaction conditions: 2,4-pentanedione (0.2 mmol) and BF3·OEt2 (0.3 mmol) were reacted in 2 mL of solvent under a nitrogen atmosphere in a Schlenk tube for 2 h. Then vanillin (0.2 mmol), aldehyde (3, 0.2 mmol), tributyl borate (0.4 mmol) and butylamine (0.04 mmol) were added subsequently, and the reaction was continued for several hours.
The reaction was monitored by TLC.
Isolated yields.
Finally, we employed 2a as a model compound to investigate whether the difluoroboron-complex can be deprotected to deliver curcumin efficiently. As shown in Scheme 3, the boron-complex can be deprotected in DMSO-MeOH at 100 °C to afford curcumin in 90% yield, thus confirming that this method can be employed to produce curcumin analogues with substituents on the phenolic oxygens in both symmetric and unsymmetric formats efficiently.
Scheme 3.

Deprotection of BF2 group from Difluoroboron-derivatized Curcumin
In summary, we have developed a concise and efficient method to allow the one-pot synthesis of difluoroboron-derivatized curcumins (BF2C) employing a BF3·OEt2-promoted system. When mono aldehyde is employed in the reaction, the s-BF2C can be obtained in good to excellent yields. The improved yield could be due to the precipitation of the product from the solvent of toluene, thus driving the reaction to completion. When two different aldehydes were introduced into this one-pot reaction system, the reaction afforded the us-BF2C in moderate yield. Lastly, this method could also be an efficient choice for preparation of curcumin analogues. Based on the scope of this method and the commercial availability of starting materials, this method should be of high interests for both organic and pharmaceutical chemistry research.
Supplementary Material
Acknowledgment
We thank Professor Glen E. Kellogg (Department of Medicinal Chemistry, Virginia Commonwealth University) for insightful discussions and comments. The work was supported in part by Alzheimer’s & Related Diseases Research Award Fund, Commonwealth of Virginia (S.Z.), and supported in part by the NIA of the NIH under award number R01AG041161 (S.Z.).
Footnotes
Supplementary data. Supplementary data associated with this article can be found in the online version.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.Govindarajan VS. Crit. Rev. Food Sci. Nutr. 1980;12:199. doi: 10.1080/10408398009527278. [DOI] [PubMed] [Google Scholar]
- 2 (a).Nurfina AN, Reksohadiprodjo MS, Timmerman H, Jenie UA, Sugiyanto D, Van der Goot H. Eur. J. Med. Chem. 1997;32:321. [Google Scholar]; (b) Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Mol. Pharmaceutics. 2007;4:807. doi: 10.1021/mp700113r. [DOI] [PubMed] [Google Scholar]
- 3.Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Life Sci. 2006;78:2081. doi: 10.1016/j.lfs.2005.12.007. [DOI] [PubMed] [Google Scholar]
- 4.Motterlini R, Foresti R, Bassi R, Green CJ. Free Radic. Biol. Med. 2000;28:1303. doi: 10.1016/s0891-5849(00)00294-x. [DOI] [PubMed] [Google Scholar]
- 5.Manikandan P, Sumitra M, Aishwarya S, Manohar BM, Lokanadam B, Puvanakrishnan R. Int. J. Biochem. Cell Biol. 2004;36:1967. doi: 10.1016/j.biocel.2004.01.030. [DOI] [PubMed] [Google Scholar]
- 6.Gafner S, Lee S-K, Cuendet M, Barthelemy S, Vergnes L, Labidalle S, Mehta RG, Boone CW, Pezzuto JM. Phytochemistry. 2004;65:2849. doi: 10.1016/j.phytochem.2004.08.008. [DOI] [PubMed] [Google Scholar]
- 7.Pillai GR, Srivastava AS, Hassanein TI, Chauhan DP, Carrier E. Cancer Lett. 2004;208:163. doi: 10.1016/j.canlet.2004.01.008. [DOI] [PubMed] [Google Scholar]
- 8.Ohtsu H, Xiao Z, Ishida J, Nagai M, Wang HK, Itokawa H, Su CY, Shih C, Lee YF, Tsai MY, Chang C, Lee KH. J. Med. Chem. 2002;45:5037. doi: 10.1021/jm020200g. [DOI] [PubMed] [Google Scholar]
- 9.Aggarwal BB, Kumar A, Bharti AC. Anticancer Res. 2003;23:363. [PubMed] [Google Scholar]
- 10.Gururaj A, Belakavadi M, Venkatesh D, Marme D, Salimath B. Biochem. Biophys. Res. Commun. 2002;297:934. doi: 10.1016/s0006-291x(02)02306-9. [DOI] [PubMed] [Google Scholar]
- 11.Sui Z, Salto R, Li J, Craik C, Ortiz de Montellano PR. Bioorg. Med. Chem. 1993;1:415. doi: 10.1016/s0968-0896(00)82152-5. [DOI] [PubMed] [Google Scholar]
- 12.Ran C, Xu X, Raymond SB, Ferrara BJ, Neal K, Bacskai BJ, Medarova Z, Moore A. J. Am. Chem. Soc. 2009;131:15257. doi: 10.1021/ja9047043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Chaicham A, Kulchat S, Tumcharern G, Tuntulani T, Tomapatanaget B. Tetrahedron. 2010;66:6217. [Google Scholar]
- 14.Pabon HJJ. Rec. Trav. Chim. Pays-Bas. 1964;83:379. [Google Scholar]
- 15.Lenhart JA, Ling X, Gandhi R, Guo TL, Gerk PM, Brunzell DH, Zhang S. J. Med. Chem. 2010;53:6198. doi: 10.1021/jm100601q. [DOI] [PubMed] [Google Scholar]
- 16.Liu K, Guo TL, Chojnacki J, Lee HG, Wang X, Siedlak SL, Rao W, Zhu X, Zhang S. ACS Chem. Neurosci. 2012;3:141. doi: 10.1021/cn200122j. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Liu K, Gandhi R, Chen J, Zhang S. ACS Med. Chem. Lett. 2012;3:942. doi: 10.1021/ml300229y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ruijter E, Scheffelaar R, Orru VA. Angew. Chem. Int. Ed. 2011;50:6234. doi: 10.1002/anie.201006515. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
